Tailwinds May Shield Hospice Bottom Lines from Coronavirus Fallout

Despite recent hits on the overall markets, hospice company revenues may be protected by the growing demand for their services. The U.S. stock markets took a major blow due to turmoil stemming from volatile oil prices and the continuing economic impact of the global COVID 19 outbreak. Monday’s drop — the worse since 2008 — caused […]

Acquisitions Continue to Drive Amedisys’ Hospice Growth

Acquisitions contributed significantly to the Amedisys (AMED) hospice segment growth during the fourth quarter of 2019, continuing a trend for the past several quarters.  The company was active in the hospice M&A space last year, completing several transactions that included its $340 million purchase of Compassionate Care Hospice in February and its tuck-in of RoseRock […]

Investors Lean Towards Hospice Amid Disruption in Home Health Space

Investors and companies seeking strategic acquisitions are showing rising interest in an already booming hospice M&A market as they await the fallout from home health care’s transition to the Patient Driven Groupings Model (PDGM), according to an analysis by Provident Healthcare Partners, an investment bank focused on the middle market in the health care space. […]

Hospice Saw Largest 2019 M&A Deals in Care-at-Home Sector

Hospice led the charge on mergers and acquisitions during 2019. Dollar amounts for hospice transactions surpassed those in similar markets such as home health care, even though fewer deals occurred last year in the hospice, home health care and home care spaces than in 2018, according to a new quarterly M&A report from advisory firm […]

Amedisys Poised for 2020 Hospice Growth

Hospice, home health, and personal care provider Amedisys Inc. (NASDAQ: AMED) is poised for further growth in the hospice space during 2020 thanks to admissions growth, acquisitions and de novo activity.  In the third quarter of 2019 Amedisys hospice segment revenue rose to $162 million, a 57% increase over Q3 2018. The segment’s EBITDA rose […]

Amedisys Closes Asana Hospice Acquisition

Amedisys, Inc. (NASDAQ: AMED) has closed its purchase of Asana Hospice for an undisclosed amount. Asana Hospice, which operates eight locations in Pennsylvania, Ohio, Missouri, Kansas and Texas, has an average daily census of 540. Following closure of this transaction, Amedisys hospice portfolio will rise to 146 locations in 33 states. “Since our founding, Asana […]

Amedisys to Purchase Asana Hospice

Amedisys, Inc. (NASDAQ: AMED) has entered into a definitive agreement to purchase Asana Hospice for an undisclosed amount. The transaction is expected to close Jan. 1, 2020. Amedisys has been doubling down on hospice acquisitions this year, building up its hospice footprint as the company braces for disruption to its home health care business stemming […]

The Top 10 Largest Hospice Providers of 2019

Though the hospice space remains fragmented, mergers and acquisitions are driving up market share, particularly for large providers. Along with service diversification and application of emerging technologies, M&A is helping to drive growth among the organizations named in LexisNexis Top 100 Hospices of 2019. With 4.5% of market share, VITAS Healthcare, a subsidiary of Chemed […]

Hospices Design Programs for Unique Needs of Military Veterans

As U.S. veterans age with the general population, hospices nationwide are designing programs and engaging in partnerships designed to meet the unique medical, psychological and emotional needs of veterans during the end of life. Roughly 18.2 million military veterans live in the United States, according to the most recent numbers from the U.S. Census Bureau, […]

Acquisitions Spur Amedisys’ Hospice Growth

Amedisys Inc. (NASDAQ: AMED) is continuing to use acquisitions to build up its hospice footprint as the company braces for disruption to its home health care business stemming from the forthcoming transition to the patient driven groupings model (PDGM).  In the third quarter of 2019 Amedisys hospice segment revenue rose to $162 million, a 57% […]